Talk:Extrapyramidal symptoms

From Wikipedia, the free encyclopedia
Jump to: navigation, search
WikiProject Medicine / Neurology (Rated Start-class, Low-importance)
WikiProject icon This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.
Start-Class article Start  This article has been rated as Start-Class on the project's quality scale.
 Low  This article has been rated as Low-importance on the project's importance scale.
Taskforce icon
This article is supported by the Neurology task force.

EPS of atypical antipsychotics[edit]

I doubt that this statement is properly backed by the cited reference: "However, some research has shown that atypical antipsychotics are just as likely as conventional antipsychotics to cause EPS. [1]" This should be reviewed! — Preceding unsigned comment added by (talk) 09:43, 29 April 2015 (UTC)

alternates can cause same problems[edit]

The Extrapyramidal symptoms#Treatment section says that some "atypical antipsychotic, such as aripiprazole" can be used as an alternative to medicines that cause these symptoms. Well, aripiprazole has a potential side effect of Extrapyramidal disorder. I'd remove it from the article, but some of the others might have the same side effect. At minimum, it should state the atypical ones can have the same problems. MeekMark (talk) 04:57, 23 March 2010 (UTC)

The above comment is altogether correct. Second generation anti-psychotics are no better than first generation in terms of efficacy or side effects. The article is remiss in not citing or sending readers to the Catie study (NEJM). Almost reads like a drug company promo. (Dec 2010)(CU) —Preceding unsigned comment added by (talk) 17:20, 12 December 2010 (UTC)

great article! I agree with the spirit of the above statements however, the side effect profile of conventional and atypical agents is quite different and this difference should be highlighted. Antipsychotic induced DM may be worse than EPS. From my experience and reading atypical agents are much less likely to produce many extra pyramidal SE. I would appreciate additional clarification of Tardive dyskenisias classification. Shatzberg's Essentials of Clinical Psychopharmacology lists TD within his section on EPS. Clinically it is important to differentiate between TD the other symptoms of EPS as the treatment/theoretical mechanism of action is different, however is it also not a movement disorder related to dysfunction of the extra-pyramidal system? feedback is appreciated —Preceding unsigned comment added by (talk) 19:45, 15 January 2011 (UTC)


I suffer from EPS since several months. What helps me is to eat fish, and not fishoil-products. What also helps is avoiding coffee and tea -which I loved! If I get an attack of EPS I do physical exercise untill I am fully exhausted. Then I take a cold shower and go to bed. Very often the next morning I am symptomfree. This may sound "naive" but it works with me. Take courage, and comment what I wrote, your friend "foodmatters" Foodmatters (talk) 00:26, 2 December 2012 (UTC)